Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1794)	11/7/2007 9:37:28 AM
From: Jibacoa	Read Replies (1) of 3722

ONXX has continued its UT & is due to open with an UG after reporting its 3rdQ results yesterday in which revenues from Nexavar increased 29% on a sequential basis & 130% compared with the 3rdQ in 2006. bigcharts.marketwatch.com BAY has also done OK in spite of the recent problems with its Trasylol. The stock has gone from 50 to 80 this Yr. also with the help of Nexavar.<g> Nexavar is currently approved for the treatment of advanced kidney cancer in the U.S. & Europe & was also approved last week in Europe for treatment of patients with liver cancer. ONXX has consistently trimmed its losses in the last 4Qs, closed on the black for the 3rdQ & is expected to be on the black in 2008. It never bothered to close its Feb 16 UG.<g> bigcharts.marketwatch.com In spite of the poor cooperation from the general market, it seems that ONXX won't have any problem in testing its May 2004 H at 60.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next